Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Macri

Showing results (111-120 of 114) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 114 results.
Science (New York, N.Y.)|November 10, 2012
Development and disintegration of Maya political systems in response to climate changeDouglas J Kennett, Sebastian F M Breitenbach, Valorie V Aquino, et al.
Paediatric and Perinatal Epidemiology|November 19, 2014
The Canadian healthy infant longitudinal development birth cohort study: biological samples and biobankingT J Moraes, D L Lefebvre, R Chooniedass, et al.
Investigational New Drugs|April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancersHui K Gan, Sagun Parakh, F T Lee, et al.
Cancer Cell|July 11, 2023
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinomaThomas M Carroll, Joseph A Chadwick, Richard P Owen, et al.
Pageof 12

Showing results (111-120 of 114) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 114 results.
Science (New York, N.Y.)|November 10, 2012
Development and disintegration of Maya political systems in response to climate changeDouglas J Kennett, Sebastian F M Breitenbach, Valorie V Aquino, et al.
Paediatric and Perinatal Epidemiology|November 19, 2014
The Canadian healthy infant longitudinal development birth cohort study: biological samples and biobankingT J Moraes, D L Lefebvre, R Chooniedass, et al.
Investigational New Drugs|April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancersHui K Gan, Sagun Parakh, F T Lee, et al.
Cancer Cell|July 11, 2023
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinomaThomas M Carroll, Joseph A Chadwick, Richard P Owen, et al.
Pageof 12